Showing results (1-10 of 51) with videos related to
Sort By:
Pageof 6
Essays in Biochemistry|August 3, 2023
Harnessing neutrophil plasticity for HCC immunotherapyErik Ramon-Gil, Daniel Geh, Jack LeslieJournal of Hepatology|February 14, 2022
Metabolic dysfunction and cancer in HCV: Shared pathways and mutual interactionsJack Leslie, Daniel Geh, Ahmed M Elsharkawy, et al.Scientific Reports|January 5, 2024
Synthesis and preclinical evaluation of a <sup>89</sup>Zr-labelled human single chain antibody for non-invasive detection of hepatic myofibroblasts in acute liver injuryToni A Pringle, Erik Ramon-Gil, Jack Leslie, et al.Nature Reviews. Gastroenterology & Hepatology|January 13, 2022
Neutrophils as potential therapeutic targets in hepatocellular carcinomaDaniel Geh, Jack Leslie, Rob Rumney, et al.Hepatology (Baltimore, Md.)|September 11, 2022
c-Rel-dependent Chk2 signaling regulates the DNA damage response limiting hepatocarcinogenesisJack Leslie, Jill E Hunter, Amy Collins, et al.Hepatology Communications|May 16, 2025
Precision-cut tumor slices for modeling hepatocellular carcinoma enable at-scale drug screeningAmy L Collins, Keara Kirkness, Erik Ramon-Gil, et al.Hepatology (Baltimore, Md.)|June 22, 2021
Immunomodulatory Effects of Lenvatinib Plus Anti-Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular CarcinomaLaura Torrens, Carla Montironi, Marc Puigvehí, et al.Expert Review of Clinical Immunology|March 16, 2018
Epratuzumab for the treatment of systemic lupus erythematosusDaniel Geh, Caroline GordonCommunications Biology|March 6, 2024
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancerRebecca Garnham, Daniel Geh, Ryan Nelson, et al.Hepatobiliary Surgery and Nutrition|February 12, 2021
Hepatocellular carcinoma in non-alcoholic fatty liver disease-a review of an emerging challenge facing cliniciansDaniel Geh, Derek M Manas, Helen L ReevesPageof 6